Bin Cai

Bin Cai's work experience starts in 2001 at Novartis Pharmaceutical, where they served as the Director of Epidemiology. In this role, they gained expertise in designing and conducting clinical trials and epidemiological studies. They also led the establishment of an in-house analytic system and team for observational studies. Additionally, Bin Cai taught courses on biostatistics, epidemiology, and research design. In 2013, they joined Allergan as the Director of Epidemiology. In 2014, they moved to Shire, where they worked as an Epidemiology leader until 2018. Finally, in 2015, Bin Cai joined Shionogi Inc. as the Sr. Director and later became the Head of Global Epidemiology and Real World Evidence in April 2020.

Bin Cai's education history includes attending the Boston University School of Public Health, the Harvard T.H. Chan School of Public Health, TongJi Medical College of HUST, and Walden University. However, specific details such as the start and end years, degree names, and fields of study are not provided.